Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats

International Archives of Allergy and Immunology

Volumn 111, Issue 1, 1996, Pages 36-43

  Diaz, B L ^a   Serra, M F ^a   Alves, A C ^a   Pires, A L A ^a   Correa F M A ^b   Cordeiro, R S B ^a   Martins, M A ^a   Esilva, P M R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allergic pleurisy; Diabetes; Eosinophils; Mast cells

Indexed keywords

ALLERGEN; ALLOXAN; COMPOUND 48-80; HISTAMINE; INSULIN; LEUKOTRIENE B4; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; DIABETES MELLITUS; EOSINOPHIL; EOSINOPHILIA; LEUKOCYTE COUNT; MALE; MAST CELL; MAST CELL DEGRANULATION; MONONUCLEAR CELL; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0029834654     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237343     Document Type: Article

References (32)

1. Larkin JCI, Frier BM, Ireland J: Diabetes melli-tusand infection. Postgrad Med.I 1985;61:233-237.
2. Rerup CC: Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970;22:485-518.
3. Lukens FDW: Alloxan diabetes. Physiol Rev 1948;28:304-328.
4. Garcia-Leme J, Ilamamura L, Migliorini RH, Leite MP: Inllucnee of diabetes upon the inflammatory response of the rat: A pharmacological study. Fur J Pharmacol 1973:23:74-81.
5. Garcia-Leme J, Farsky SP: Hormonal control of inflammatory responses. J Lipid Médiat 1992; 2:181-198.
6. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H: Infection and diabetes: The ease for glucose control. Am J Med 1982; 72:439-450.
7. Garcia-Leme J, Bohm GM, Migliorini RH, Souza MZA: Possible participation of insulin in the control of vascular permeability. Eur J Pharmacol 1974:29:298-306.
8. Wertman KF, Ilenney MR: The effects of alloxan diabetes on phagocytosis and susceptibility to infection. J Immunol 1962:89:314-317.
9. Mowat AG, Baum J: Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971:284:621-624.
10. Holgate ST, Djukanovic R, Wilson J, Roche W, Horwath PH: Inflammatory processes and bronchial hypcrresponsivcncss. Clin Exp Allergy 1991;21:30-32.
11. Iwamoto I, Tomoe S, Tomioka H, Takatsu K, Yoshida S: Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J Leukocyte Biol 1992:52: 572-578.
12. 4 from mouse bone-marrovv derived mast cells. J Immunol 1983:130:1885-1889.
13. Helander E: Asthma and diabetes. Acta Med Scand 1958;162:166-174.
14. Lasser E: Asthma and diabetes mellitus: A bronchemical basis for antithetical features. Med Hypotheses 1987;23:95-106.
15. Lima MCR, Martins MA, Perez SAC, Peixoto JM, Silva PMR, Cordeiro RSB: Kinetics of exudation and cellular alterations induced by antigen in actively sensitized rats. Braz J Med Biol Res 1990;23:857-860.
16. Silva PMR, Martins MA, Lima MCR, Alves AC, Diaz BL, Cordeiro RSB: Pharmacological modulation of the late cosinophilia induced by antigen in actively sensitized rats. Int Arch Allergy Immunol 1992:98:355-360.
17. Bozza PT, Castro-Faria-Neto HC, Penido C, La-rangeira AP, Silva PMR, Martins MA: IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by PAF. I mmunophannacology 1994;27:131-136.
18. Martins MA, Etienne A, Soulard C, Domingo MT, Braquet P: Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats. Braz J Med Res 1989:22:1151-1154.
19. Corréa FMA, Saavedra JM: Increase in histamine concentrations in discrete hypothalamic nuclei of spontaneously hypertensive rats. Brain Res 1981:205:445-451.
20. Lima MCR, Martins MA, Perez SAC, Silva PMR, Cordeiro RSB, Vargaftig BB: Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats. Eur J Pharmacol 1991:197:201-207.
21. Vianna ESO, Garcia-Leme J: Allergen-induced airway inflammation in rats. Am J Respir C'rit Med 1995:151:809-814.
22. Galli SJ: New concepts about mast cell. N Engl J Med 1993:328:257-265.
23. Sollcy G, Gleich GJ, Jordon R, Schoeter AL: The late phase of the immediate wheal and flare skin reaction: Its dependence upon IgE antibodies. J Clin Invest 1976:58:408-420.
24. Casacó A, Carvajal D, Tolón Z: Diabetes-induced rat hyposensitivity to compound 48/80. Can J Physiol Pharmacol 1991:69:886-888.
25. Martins MA, Pasquale CMP, Silva PMR, Cor-deiro RSB, Vargaftig BB: Eosinophil accumulation in the rat pleural cavity after mast cell stimulation with compound 48/80 involves protein synthesis and is selectively suppressed by dcxamethasone. Int Arch Allergy Appl Immunol 1990:92:416-424.
26. Ptak W, Rcwicka M, Gryglewski A, Bielecka J: Differential effect of experimental diabetes on the early and late phase ofcontact sensitivity reaction in mice. Int Arch Allergy Appl Immunol 1986;81:136-140.
27. Strauss DS: Growth stimulatory actions of insulin in vitro and in vivo. Endocr Rev 1984;5: 356-369.
28. Lavker RM, Schechter NM: Cutaneous mast cell depiction results from topical corticosteroid usage. J Immunol 1985:135:2368-2373.
29. Nunes MT, Curi R: Hyperthyroid-like metabolic changes induced by chronic administration of compound BW 48/80. Braz J Med Biol Res 1989;22:417-420.
30. Wexler BC, Lutmer RF: Adrenal glandular lipids and circulating corticosterone in severely diabetic rats. Br J Exp Pathol 1975:56:299-306.
31. Oster MH, Castonguay TW, Keen CL, Stem JS: Circadian rhythm of corticosterone in diabetic rats. Life Sci 1988:43:1643-1645.
32. Pereira MAA, Sannontiya P, Garcia-Leme J: Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes 1987:36:1307-1314.